A Florida-based charity will pay $4 million to resolve claims that it acted as a conduit for companies including Biogen Inc  and Novartis AG  to pay kickbacks to Medicare patients using their high-priced multiple sclerosis drugs, the U.S. Justice Department said on Wednesday.
